Increased risk of tuberculosis in patients with end-stage renal disease: a population-based cohort study in Taiwan, a country of high incidence of end-stage renal disease

被引:22
|
作者
Hu, H. Y. [1 ,2 ]
Wu, C. Y. [1 ]
Huang, N. [2 ,3 ]
Chou, Y. J. [1 ]
Chang, Y. C. [4 ]
Chu, D. [1 ,5 ]
机构
[1] Natl Yang Ming Univ, Inst Publ Hlth, Taipei 103, Taiwan
[2] Natl Yang Ming Univ, Dept Publ Hlth, Taipei 103, Taiwan
[3] Taipei City Hosp, Heping Fuyou Branch, Inst Hosp & Hlth, Taipei, Taiwan
[4] Asia Univ, Dept Healthcare Adm, Taichung, Taiwan
[5] Taipei City Hosp, Dept Neurosurg, Taipei, Taiwan
来源
EPIDEMIOLOGY AND INFECTION | 2014年 / 142卷 / 01期
关键词
Cohort study; end-stage renal disease; Taiwan; tuberculosis; DIALYSIS PATIENTS; HEMODIALYSIS;
D O I
10.1017/S0950268813000551
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
This nationwide population-based cohort study investigated the risk of tuberculosis (TB) in patients with end-stage renal disease (ESRD) and receiving dialysis. The evaluations included 4131 incident ESRD patients receiving dialysis and 16524 age- and gender-matched controls, recruited between 1998 and 2009. We used Cox proportional hazards regression analysis to measure the association between TB and ESRD. Compared to the controls, the ESRD cohort had a significantly higher risk of TB within 1 year [incident rate ratio (IRR) 413], and 1-2 years (IRR 212), of occurrence of ESRD. The Cox proportional hazards model revealed that ESRD [hazard ratio (HR) 240], age >65 years (HR 241), male sex (HR 194), diabetes mellitus (HR 136), silicosis (HR 770) and chronic obstructive pulmonary disease (HR 161) are independent risk factors for TB. Patients with ESRD are associated with an increased risk of TB, and should thus be monitored more carefully for TB, especially within 2 years of onset of ESRD.
引用
收藏
页码:191 / 199
页数:9
相关论文
共 50 条
  • [41] Risk of end-stage renal disease in systemic lupus erythematosus patients: a nationwide population-based study
    Yu, Kuang-Hui
    Kuo, Chang-Fu
    Chou, I-Jun
    Chiou, Meng-Jiun
    See, Lai-Chu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (11) : 1175 - 1182
  • [42] Association between NSAID use and mortality risk in patients with end-stage renal disease: a population-based cohort study
    Lai, Ka Man
    Chen, Ta-Liang
    Chang, Chuen-Chau
    Chen, Hsi-Hsien
    Lee, Yuan-Wen
    CLINICAL EPIDEMIOLOGY, 2019, 11 : 429 - 441
  • [43] INCIDENCE AND RISK FACTORS ASSOCIATED WITH SYPHILIS IN THE END-STAGE RENAL DISEASE POPULATION
    Weathers, E.
    Waller, J.
    Colombo, R.
    Kheda, M.
    Turrentine, J. E.
    Nahman, N. S.
    Baer, S.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2017, 65 (02) : 644 - 644
  • [44] RISK OF SPINAL EPIDURAL ABSCESS INFECTION IN END-STAGE RENAL DISEASE PATIENTS: A POPULATION-BASED STUDY
    Hwang, J.
    Jiang, M.
    Lu, Y.
    Wen, S.
    NEPHROLOGY, 2016, 21 : 183 - 184
  • [45] Risk factors associated with bloodstream infections in end-stage renal disease patients: a population-based study
    Dagasso, Gabrielle
    Conley, Joslyn
    Parfitt, Elizabeth
    Pasquill, Kelsey
    Steele, Lisa
    Laupland, Kevin
    INFECTIOUS DISEASES, 2018, 50 (11-12) : 831 - 836
  • [46] Is preeclampsia a risk for end-stage renal disease?
    Ponticelli, Claudio
    Moroni, Gabriella
    KIDNEY INTERNATIONAL, 2019, 96 (03) : 547 - 549
  • [47] Homelessness and Risk of End-stage Renal Disease
    Maziarz, Marlena
    Chertow, Glenn M.
    Himmeffarb, Jonathan
    Hall, Yoshio N.
    JOURNAL OF HEALTH CARE FOR THE POOR AND UNDERSERVED, 2014, 25 (03) : 1231 - 1244
  • [48] Palliative Care of End-Stage Renal Disease in Taiwan
    Li, Hsiu-Lan
    Lin, Shih-Wei
    Tai, Pei-Hui
    2017 IEEE GREAT LAKES BIOMEDICAL CONFERENCE (GLBC), 2017,
  • [49] Renal ablation in patients with end-stage renal disease
    Hansch, A.
    Pfeil, A.
    Neumann, R.
    Neumann, S.
    Mayer, T. E.
    Wolf, G.
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2011, 40 (04) : 308 - 314
  • [50] Preeclampsia and the risk of end-stage renal disease
    Vikse, Bjorn Egil
    Irgens, Lorentz M.
    Leivestad, Torbjorn
    Skjaerven, Rolv
    Iversen, Bjarne M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (08): : 800 - 809